爱斯坦-巴尔病毒编码的EBNA2通过诱导B细胞淋巴瘤中的miR-24来降低ICOSL的调节
Martina Leopizzi1, Lucia Mundo2, Elena Messina3
1Department of Medico-surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
Blood
|October 17, 2023
概括
爱斯坦-巴尔病毒 (EBV) 蛋白EBNA2通过增加针对ICOSL的microRNA-24 (miR-24) 来降低瘤T细胞识别. 这种EBV策略有助于淋巴瘤逃避免疫反应,同时保持癌细胞生长.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 像DLBCL这样的血液恶性瘤通常与爱斯坦-巴尔病毒 (EBV) 相关,导致预后较差.
- 编码EBV的核抗原2 (EBNA2) 影响瘤细胞的免疫逃逸.
- 之前的研究表明EBNA2降低了微RNA-34a的调节,从而提高了PD-L1.
研究的目的:
- 研究EBNA2对B细胞淋巴瘤中可诱导性辅助刺激器连接体 (ICOSL) 表达的作用.
- 阐明EBNA2调节ICOSL的分子机制.
- 探索针对EBV相关淋巴瘤的microRNA-24 (miR-24) 的治疗潜力.
主要方法:
- 分析了EBV感染和EBNA2转移的B淋巴瘤细胞中的ICOSL表达.
- 使用一种光酶报告系统来验证ICOSL的miR-24向.
- 使用混合淋巴细胞反应评估瘤免疫性.
- 在抗miR-24转染细胞中检查了c-MYC表达和亡.
- 与EBNA2阳性DLBCL患者活检相关的体外发现.
主要成果:
- 在淋巴瘤细胞中,EBNA2表达降低了ICOSL水平.
- EBNA2增加了miR-24的表达,这直接针对ICOSL.
- 抑制miR-24恢复了ICOSL表达,并增强了抗瘤T细胞的反应.
- 减少了EBNA2表达DLBCL中的miR-24,增加了c-MYC和亡.
- 与EBV相关的DLBCL活检显示了低ICOSL和高miR-24.
结论:
- EBV利用EBNA2诱导miR-24,降低ICOSL的调节,并促进免疫逃避.
- 这种机制允许与EBV相关的淋巴瘤逃避宿主免疫力.
- EBNA2还维持c-MYC水平,支持瘤细胞的增殖.
- miR-24代表了EBV驱动的淋巴瘤的潜在治疗标.
更多相关视频
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.2K
08:26The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
Published on: December 14, 2016
15.3K
相关概念视频
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
